CLINICAL_TRIALS
trial_result
· 2018-10-16
Clinical Trial Update: Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures [Phase 3]
Summary
Phase 3 trial update on eslicarbazepine acetate as monotherapy for newly diagnosed partial-onset seizures.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED